Phase 2 Evaluation of Topotecan Administered on a 3-Day Schedule in the Treatment of Platinum- and Paclitaxel-Refractory Ovarian Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase 2 Evaluation of Topotecan Administered on a 3-Day Schedule in the Treatment of Platinum- and Paclitaxel-Refractory Ovarian Cancer

57

Citations

10

References

2000

Year

Maurie Markman, Alexander Kennedy, Kenneth Webster, Barbara Kulp, Gertrude Peterson, Jerome L. Belinson

Gynecologic Oncology

MedicinePharmacologyGynecologyTumor TargetingCancer TreatmentPhase 2OncologyPaclitaxel-refractory Ovarian CancerGynecology OncologyTopotecan AdministeredOvarian Cancer

References

	Year	Citations

Page 1